ReviewMolecules (Basel, Switzerland)2022

Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development.

Dibyendu Dana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.